Sélectionnée pour le projet de redécouverte R&D 2020 du MOTIE

As of May 28th, RudaCure Inc. a été sélectionnée pour le Ministère de Trade, Industry and Energy's (Announcement No. 2020-145, March 6, 2020) 2020 R&D Rediscovery Project new evaluation for the project titled [Development of source technology for traitement de la sécheresse oculaire using Rac1 inhibitor RCI001 for regulatory approval]. RudaCure is the lead institution, with detailed institutions Gil Medical Foundation and IP Darae Strategy Commercialization Center, with a total project budget of KRW 350 million per year. L'entreprise will spend the l'année prochaine developing raw material pharmaceutique production methods and standards and testing methods for RCI001.